Tibio-pedal artery access is being used with increasing frequency in lower-extremity arterial intervention, but it can be “a very complicated thing,” said interventional radiologist Brett Wiechmann, MD. He proposed to offer International Symposium…

There are two devices for large bore vessel closure for which there is extensive experience, only one of which is approved in the United States, reported Zvonimir Krajcer, MD, director of peripheral vascular disease at Texas Heart Institute.

Two-year findings from the VIRTUS trial of the VICI venous stent (Boston Scientific) showed a primary patency rate of 79.4%. As has been seen in other trials, primary patency was higher in non-thrombotic lesions (94.6%) as compared to post-…

Endovenous stenting to relieve chronic venous disease secondary to post-thrombotic or non-thrombotic iliac vein obstruction is becoming increasingly established.

George Adams, MD, MHS, MBA, presented six-month data from the Tack Optimized Balloon Angioplasty II (TOBA II) Below the Knee (BTK) trial Friday morning at the International Symposium on Endovascular Therapy (ISET).

In an afternoon session at the International Symposium on Endovascular Therapy, presenters reviewed practical tips and techniques for treating patients with complex critical limb ischemia (CLI) and peripheral arterial disease (PAD).

Hollywood, FL (January 25, 2020) – Various types of embolization were discussed during a morning session at the International Symposium on Endovascular Therapy (ISET). Speakers shared best practices for modalities such as uterine artery embolization…

Tips, techniques, and device information on large vessel access and closure were highlighted during a session at the International Symposium on Endovascular Therapy (ISET).

Hollywood, FL (January 24, 2020) – The Supera stent (Abbott Vascular) is a “fundamentally different design”, said Bret Wiechmann, MD, of Vascular & Interventional Physicians in Gainesville, Florida, in his Friday morning presentation on the…

Michael R. Jaff, DO, Vice President of Clinical Affairs, Innovation, Technology and Peripheral Interventions at Boston Scientific, presented results from the COMPARE Pilot randomized clinical trial on Friday morning at the International Symposium on…